[en] Human immunodeficiency virus (HIV)-1 is able to replicate in primary human macrophages without stimulating innate immunity despite reverse transcription of genomic RNA into double-stranded DNA, an activity that might be expected to trigger innate pattern recognition receptors. We reasoned that if correctly orchestrated HIV-1 uncoating and nuclear entry is important for evasion of innate sensors then manipulation of specific interactions between HIV-1 capsid and host factors that putatively regulate these processes should trigger pattern recognition receptors and stimulate type 1 interferon (IFN) secretion. Here we show that HIV-1 capsid mutants N74D and P90A, which are impaired for interaction with cofactors cleavage and polyadenylation specificity factor subunit 6 (CPSF6) and cyclophilins (Nup358 and CypA), respectively, cannot replicate in primary human monocyte-derived macrophages because they trigger innate sensors leading to nuclear translocation of NF-κB and IRF3, the production of soluble type 1 IFN and induction of an antiviral state. Depletion of CPSF6 with short hairpin RNA expression allows wild-type virus to trigger innate sensors and IFN production. In each case, suppressed replication is rescued by IFN-receptor blockade, demonstrating a role for IFN in restriction. IFN production is dependent on viral reverse transcription but not integration, indicating that a viral reverse transcription product comprises the HIV-1 pathogen-associated molecular pattern. Finally, we show that we can pharmacologically induce wild-type HIV-1 infection to stimulate IFN secretion and an antiviral state using a non-immunosuppressive cyclosporine analogue. We conclude that HIV-1 has evolved to use CPSF6 and cyclophilins to cloak its replication, allowing evasion of innate immune sensors and induction of a cell-autonomous innate immune response in primary human macrophages.
Disciplines :
Life sciences: Multidisciplinary, general & others
Author, co-author :
Rasaiyaah, Jane; University College London - UCL > Infection and Immunity > Medical Research Council Centre for Medical Molecular Virology
Ping Tan, Choon; University College London - UCL > Infection and Immunity > Medical Research Council Centre for Medical Molecular Virology
Fletcher, Adam; University College London - UCL > Infection and Immunity > Medical Research Council Centre for Medical Molecular Virology
Price, Amanda; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK > Protein and Nucleic Acid Chemistry Division
Blondeau, Caroline ; University College London - UCL > Infection and Immunity > Medical Research Council Centre for Medical Molecular Virology
Hilditch, Laura; University College London - UCL > Infection and Immunity > Medical Research Council Centre for Medical Molecular Virology
Jacques, David; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK > Protein and Nucleic Acid Chemistry Division
Selwood, David; University College London - UCL > Wolfson Institute for Biomedical Research
James, Leo; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK > Protein and Nucleic Acid Chemistry Division
Noursadeghi, Mahdad; University College London - UCL > Infection and Immunity > Medical Research Council Centre for Medical Molecular Virology
Towers, Greg; University College London - UCL > Infection and Immunity > Medical Research Council Centre for Medical Molecular Virology
Language :
English
Title :
HIV-1 evades innate immune recognition through specific cofactor recruitment
Publication date :
2013
Journal title :
Nature
ISSN :
0028-0836
eISSN :
1476-4687
Publisher :
Nature Publishing Group, Basingstoke, United Kingdom
Lee, K. et al. Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 7, 221-233 (2010).
Schaller, T. et al. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog. 7, e1002439 (2011).
Price, A. J. et al. CPSF6 defines a conserved capsid interface that modulates HIV-1 replication. PLoS Pathog. 8, e1002896 (2012).
Ambrose, Z. et al. Human immunodeficiency virus type 1 capsid mutation N74D alters cyclophilin A dependence and impairs macrophage infection. J. Virol. 86, 4708-4714 (2012).
Tsang, J. et al. HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation. AIDS 23, 2255-2263 (2009).
Besnier, C., Takeuchi, Y.& Towers, G. Restriction of lentivirus inmonkeys. Proc. Natl Acad. Sci. USA 99, 11920-11925 (2002).
Iyer, S. R., Yu, D., Biancotto, A., Margolis, L. B. & Wu, Y. Measurement of human immunodeficiency virus type 1 preintegration transcription by using Revdependent Rev-CEM cells reveals a sizable transcribing DNA population comparable to that from proviral templates. J. Virol. 83, 8662-8673 (2009).
Shi, J., Zhou, J., Shah, V. B., Aiken, C. & Whitby, K. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization. J. Virol. 85, 542-549 (2011).
Blair, W. S. et al. HIV capsid is a tractable target for small molecule therapeutic intervention. PLoS Pathog. 6, e1001220 (2010).
Dettwiler, S., Aringhieri, C., Cardinale, S., Keller, W. & Barabino, S. M. Distinct sequence motifs within the 68-kDa subunit of cleavage factor Im mediate RNA binding, protein-protein interactions, and subcellular localization. J. Biol. Chem. 279, 35788-35797 (2004).
Ocwieja, K. E. et al. HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2. PLoS Pathog. 7, e1001313 (2011).
Sun, L.,Wu, J.,Du, F.,Chen, X.&Chen, Z. J. CyclicGMP-AMPsynthase is acytosolicDNA sensor that activates the type I interferon pathway. Science 339, 786-791 (2013).
Gao, D. et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341, 903-906 (2013).
Dube, H. et al. A mitochondrial-targeted cyclosporin A with high binding affinity for cyclophilin D yields improved cytoprotection of cardiomyocytes. Biochem. J. 441, 901-907 (2012).
Liu, J.-P., Ye, L., Wang, X., Li, J.-L. & Ho, W.-Z. Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes. Transpl. Inf. Dis. 13, 24-32 (2011).
Yan, N., Regalado-Magdos, A. D., Stiggelbout, B., Lee-Kirsch, M. A. & Lieberman, J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nature Immunol. 11, 1005-1013 (2010).
Manel, N. et al. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467, 214-217 (2010).
Morner, A. et al. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently useCCR5but showpromiscuity in coreceptor usage. J. Virol. 73, 2343-2349 (1999).
Zhang, F., Hatziioannou, T., Perez-Caballero, D., Derse, D. & Bieniasz, P. D. Antiretroviral potential of human tripartite motif-5 and related proteins. Virology 353, 396-409 (2006).
Lee, K. et al. HIV-1 capsid-targeting domain of cleavage and polyadenylation specificity factor 6. J. Virol. 86, 3851-3860 (2012).
Ruepp, M. D., Schumperli, D.&Barabino, S. M.mRNA39 endprocessingandmore- multiple functions of mammalian cleavage factor I-68. Wiley interdisciplinary reviews. RNA 2, 79-91 (2011).
Yang, Q., Gilmartin, G. M. & Doublie, S. The structure of human cleavage factor Im hints at functions beyond UGUA-specific RNA binding: a role in alternative polyadenylation and a potential link to 59 capping and splicing. RNA Biol. 8, 748-753 (2011).
Hori, T. et al. A carboxy-terminally truncated human CPSF6 lacking residues encoded by exon 6 inhibits HIV-1 cDNA synthesis and promotes capsid disassembly. J. Virol. 87, 7726-7736 (2013).
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L. & Trono, D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nature Biotechnol. 15, 871-875 (1997).
Naldini, L. et al. In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector. Science 272, 263-267 (1996).
Négre, D. et al. Characterization of novel safe lentiviral vectors derived fromsimian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther. 7, 1613-1623 (2000).
Saeed,A. I. et al.TM4: a free, open-source systemfor microarray datamanagement and analysis. Biotechniques 34, 374-378 (2003).
Lynn, D. J. et al. Curating the innate immunity interactome. BMC Syst. Biol. 4, 117 (2010).
Butler, S. L., Hansen, M. S. & Bushman, F. D. A quantitative assay for HIV DNA integration in vivo. Nature Med. 7, 631-634 (2001).
Ishikawa, H., Ma, Z. & Barber, G. N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788-792 (2009).
Collaborative Computational Project, number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760-763 (1994).
Mikol, V., Kallen, J., Pflugl, G. & Walkinshaw, M. D. X-ray structure of a monomeric cyclophilin A-cyclosporin A crystal complex at 2.1Å resolution. J. Mol. Biol. 234, 1119-1130 (1993).